Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

Source: 
Reuters
snippet: 

A U.S. appeals court on Wednesday upheld a ruling that patents owned by Biogen Inc covering its blockbuster multiple sclerosis drug Tecfidera are valid, rejecting a challenge by Danish drugmaker Forward Pharma A/S.